← FDA DRUG APPROVALS

FDA NDA · NDA013056

PENTHRANE

Sponsor: ABBOTT

APPLICATION
NDA013056
TYPE
NDA
ORIGINAL APPROVAL
1962-05-04
LATEST ACTION
2001-09-17
ROUTE
INHALATION
DOSAGE FORM
LIQUID
MARKETING STATUS
Discontinued

Products

PENTHRANEDiscontinued
METHOXYFLURANE 99.9% · LIQUID · INHALATION

Approval history

2001-09-17Labeling · Supplement 28 · standardAP
2001-09-17Labeling · Supplement 20AP
1984-02-01Labeling · Supplement 24AP
1978-05-25Labeling · Supplement 21AP
1974-08-28Labeling · Supplement 18AP
1972-10-02Labeling · Supplement 14AP
1962-05-04Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →